logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Meta-analysis: combination therapy better for NSCLC

Better outcomes with PD-1/PD-L1 inhibitors plus chemotherapy compared with chemotherapy alone.